Statistics
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
| Views | |
|---|---|
| Evaluating ... | 1016 |
Total Visits Per Month
| August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | |
|---|---|---|---|---|---|---|---|
| Evaluating ... | 2 | 6 | 5 | 18 | 19 | 31 | 15 |
File Visits
| Views | |
|---|---|
| 21VmhogDXFlrE.pdf | 418 |
